Skip to content

To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.

Clinical Evaluation of Immunomodulatory Effect of Swarnaprashan in Children: A Prospective Open Label Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033713
Enrollment
30
Registered
2021-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D839- Common variable immunodeficiency,unspecified

Interventions

Intervention1: SwarnaPrashan: Swarnaprashan will be prescribed in 1 drop/kg /day(0.2-0.3mg Swarna bhasma per drop) for 8 weeks Control Intervention1: SwarnaPrashan: Swarnaprashan will be prescribed in

Sponsors

National Institute of Ayurveda Jaipur Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged from 2-5 years of either sex 2. Childern with recurrent respiratory infections 3. Childern with recurrent G.I.T. diseases 4. Children with recurrent fever 5. Children with recuurent episodes of diarrhea 6. Children with other recurrent diseases

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment 2. Subjects with evidence of malignancy 3. Subject with aspartate amino transferase(AST) and or alanine amino transferase ALT >3 Times of the upper normal limit and renal dysfunction (Sr. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction( asthmatic and COPD patients) . 4. Co-morbidity like TB, UTI and bleeding disorders etc 5. Congenital anomalies and hereditary disease. 6. Pulmonary or abdominal tuberculosis. 7. H/O hypersensitivity to any of the trial drug or any of its ingredients. 8. Subjects who have completed participation in any other clinical trial during the past six months. 9. Any contraindications mentioned for Lehan karma in Kashyap Samhita.

Design outcomes

Primary

MeasureTime frame
To Observe the Immunomodulatory effect of Swarnaprashan.Timepoint: 8 weeks

Secondary

MeasureTime frame
Reduction in Morbidity rate in children.Timepoint: 8 weeks

Countries

India

Contacts

Public ContactDrNisha Kumari Ojha

National Institute of Ayurveda Jaipur, Rajasthan

drnishaojha@gmail.com9468650449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026